NPPA caps retail prices of 30 drug formulations spanning diabetes, BP, heart and antibiotics
India's drug pricing regulator NPPA has fixed ceiling prices on 30 formulations, with new caps including Rs 14.88/tablet, Rs 11.91/tablet and Rs 127/capsule across diabetes, hypertension, cardiac and women's health categories. Chemist body AIOCD expects revised MRP stock on pharmacy shelves within 60-90 days as existing inventory clears.
NPPA capped retail prices of 30 drug formulations covering diabetes, BP, heart, antibiotics and women's health. Chemists expect revised MRP stock to hit pharmacy shelves within 60-90 days after existing inventory clears.
Why this matters
NPPA continues its routine ceiling-price revisions on essential formulations, this round widening coverage to 30 drugs across chronic-care categories that dominate Indian retail pharmacy footfall.
Retail-brand signals steady at 785 in last 90 days, indicating consistent regulatory and pricing activity.